FDA Inspection
Vitalant Reference and Transfusion ServiceVitalant Reference and Transfusion Service – FDA Inspection, May 10, 2017
Record Details
This FDA Inspection record concerns Vitalant Reference and Transfusion Service, with an inspection on May 10, 2017, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 05855e4a-f27b-4750-853c-60e02e9ad388
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1012215
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 606.160(a)(1)Concurrent documentation
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Vitalant Reference and Transfusion Service
5| Date | Classification | Office | Project area |
|---|---|---|---|
| September 13, 2019 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 21, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 7, 2013 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 12, 2011 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| October 16, 2009 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Vitalant Reference and Transfusion Service
- FDA Inspection 1101918 - 2019-09-13
- FDA Inspection 927005 - 2015-05-21
- FDA Inspection 817766 - 2013-02-07
- FDA Inspection 724484 - 2011-05-12
- FDA Inspection 620701 - 2009-10-16
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.